Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Clinical Challenges: Second-Line Treatment for NSCLC After Failure of Immunotherapy – MedPage Today
    Clinical Challenges: Second-Line Treatment for NSCLC After Failure of Immunotherapy – MedPage Today
  • Manipulating proteins to make ‘cold’ tumors responsive to immunotherapies – FierceBiotech
    Manipulating proteins to make ‘cold’ tumors responsive to immunotherapies – FierceBiotech
  • Research uncovers clues in use of immunotherapy for breast cancer – Medical Xpress
    Research uncovers clues in use of immunotherapy for breast cancer – Medical Xpress
  • NIH investigators hope CD47 study leads to broad-spectrum infectious diseases immunotherapy – National Institutes of Health
  • CheckMate 227 Induced Manageable Toxicities With Immunotherapy Combination in NSCLC – Targeted Oncology
    CheckMate 227 Induced Manageable Toxicities With Immunotherapy Combination in NSCLC – Targeted Oncology
  • Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles – PRNewswire
  • Engineering an immunotherapy to outwit cancer — and launch a biotech – STAT
    Engineering an immunotherapy to outwit cancer — and launch a biotech – STAT
  • Cancer Immunotherapy Tied to Severe COVID-19 Outcomes – MedPage Today
    Cancer Immunotherapy Tied to Severe COVID-19 Outcomes – MedPage Today
  • Looking at Immunotherapies for Patients with Metastatic Prostate Cancer – Curetoday.com
    Looking at Immunotherapies for Patients with Metastatic Prostate Cancer – Curetoday.com
  • New Immunotherapy Combinations Look to Create Maximum Velocity in Immune Systems Response to Cancer – Curetoday.com
    New Immunotherapy Combinations Look to Create Maximum Velocity in Immune Systems Response to Cancer – Curetoday.com
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com